Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Petros Koufopoulos

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Antibiotics (Basel, Switzerland)|September 27, 2025
The Impact of COVID-19 on the Epidemiology of Carbapenem ResistanceAikaterini Sakagianni, Christina Koufopoulou, Petros Koufopoulos, et al.
Antibiotics (Basel, Switzerland)|October 25, 2024
The Synergy of Machine Learning and Epidemiology in Addressing Carbapenem Resistance: A Comprehensive ReviewAikaterini Sakagianni, Christina Koufopoulou, Petros Koufopoulos, et al.
Biomolecules|November 27, 2024
Anti-Diabetic Therapies and Cancer: From Bench to BedsideDimitris Kounatidis, Natalia G Vallianou, Irene Karampela, et al.
Diagnostics (Basel, Switzerland)|October 25, 2024
Cardiac Troponin Levels in Patients with Chronic Kidney Disease: "Markers of High Risk or Just Noise''?Eleni V Geladari, Natalia G Vallianou, Angelos Evangelopoulos, et al.
Biomolecules|July 27, 2024
Third-Generation Tetracyclines: Current Knowledge and Therapeutic PotentialDimitris Kounatidis, Maria Dalamaga, Eugenia Grivakou, et al.
Antibiotics (Basel, Switzerland)|November 27, 2024
Data-Driven Approaches in Antimicrobial Resistance: Machine Learning SolutionsAikaterini Sakagianni, Christina Koufopoulou, Petros Koufopoulos, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Antibiotics (Basel, Switzerland)|September 27, 2025
The Impact of COVID-19 on the Epidemiology of Carbapenem ResistanceAikaterini Sakagianni, Christina Koufopoulou, Petros Koufopoulos, et al.
Antibiotics (Basel, Switzerland)|October 25, 2024
The Synergy of Machine Learning and Epidemiology in Addressing Carbapenem Resistance: A Comprehensive ReviewAikaterini Sakagianni, Christina Koufopoulou, Petros Koufopoulos, et al.
Biomolecules|November 27, 2024
Anti-Diabetic Therapies and Cancer: From Bench to BedsideDimitris Kounatidis, Natalia G Vallianou, Irene Karampela, et al.
Diagnostics (Basel, Switzerland)|October 25, 2024
Cardiac Troponin Levels in Patients with Chronic Kidney Disease: "Markers of High Risk or Just Noise''?Eleni V Geladari, Natalia G Vallianou, Angelos Evangelopoulos, et al.
Biomolecules|July 27, 2024
Third-Generation Tetracyclines: Current Knowledge and Therapeutic PotentialDimitris Kounatidis, Maria Dalamaga, Eugenia Grivakou, et al.
Antibiotics (Basel, Switzerland)|November 27, 2024
Data-Driven Approaches in Antimicrobial Resistance: Machine Learning SolutionsAikaterini Sakagianni, Christina Koufopoulou, Petros Koufopoulos, et al.
Pageof 1